Tempest Therapeutics Inc (TPST) — Capital Reinvestment Ratio
Latest as of June 2021:
0.55x
Tempest Therapeutics Inc (TPST) has a Capital Reinvestment Ratio of 0.55x as of June 2021, meaning it reinvests 1% of its operating cash flow ($127.00K) in capital expenditures ($70.00K). Check Tempest Therapeutics Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
0.55x
Capex / Operating Cash Flow
Operating Cash Flow
$127.00K
USD
Capital Expenditures
$70.00K
USD
Data as of
Jun 2021
Most recent filing
Annual Capital Reinvestment Ratio for Tempest Therapeutics Inc (None–None)
Year-by-year Capital Reinvestment Ratio for Tempest Therapeutics Inc from None to None. See Tempest Therapeutics Inc (TPST) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow